China AI Lab Minimax hits $48.9B in market cap, topping Baidu's
TL;DR
China's AI startup Minimax reached a market cap of $48.9 billion, surpassing Baidu, driven by its global strategy and cost-effective solutions. Its success highlights China's unique AI development path focused on efficiency and industrial adoption.
Tags
China’s AI startup Minimax has seen its market capitalization surge to $48.9 billion as of March 10, 2026, surpassing that of Baidu, the Chinese tech giant. This follows Minimax’s initial public offering (IPO) in January 2026, during which it raised HK$4.8 billion ($619 million) in Hong Kong, one of three Chinese AI firms to list within days of each other. The rapid valuation growth reflects investor confidence in Minimax’s strategy of targeting international markets and optimizing for efficiency amid capital constraints typical of China’s AI sector.
Unlike U.S. counterparts, which prioritize frontier model development through heavy capital investment, Minimax and other Chinese startups focus on cost-effective deployment and tailored solutions for enterprise clients. For example, Minimax’s AI companion and role-play apps, such as Talkie, have attracted over 212 million users globally, with overseas markets contributing over 70% of revenue. This “born-global” approach aligns with China’s fragmented industrial landscape, where regional and sector-specific demand allows niche players to thrive despite competition from tech giants like Alibaba and ByteDance.
China’s AI ecosystem remains underfunded relative to the U.S., with private investment in 2024 totaling $9.3 billion for Chinese startups versus $109.1 billion for U.S. firms. However, government subsidies, such as “computing vouchers” covering up to 80% of cloud costs, and a focus on industrial adoption—67% of Chinese manufacturers have deployed AI—have accelerated practical implementation. Minimax’s success underscores how economic pressures and market dynamics in China are shaping a distinct AI development trajectory, emphasizing scalability and operational outcomes over pure research dominance.